Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome

Clinical and Experimental Immunology

Volumn 104, Issue 3, 1996, Pages 454-459

  Bacman, S ^a   Sterin Borda, L ^a   Camusso, J José ^a   Arana, R ^a   Hubscher, O ^a   Borda, E ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

Antibodies; M3 muscarinic receptors; Parotid gland; Primary Sj gren's syndrome

Indexed keywords

ATROPINE; AUTOANTIBODY; CARBACHOL; CYCLIC AMP; CYCLIC GMP; IMMUNOGLOBULIN G; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; PHOSPHATIDYLINOSITIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; PAROTID GLAND; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SJOEGREN SYNDROME;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; ANIMALS; ANTIBODIES, BLOCKING; ATROPINE; CARBACHOL; CARBAMATES; CYCLIC AMP; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOGLOBULIN G; ISOPROTERENOL; MUSCARINIC ANTAGONISTS; PARASYMPATHOLYTICS; PAROTID GLAND; PHENYLCARBAMATES; PHOSPHATIDYLINOSITOLS; PIPERIDINES; PIRENZEPINE; PROTEASE INHIBITORS; QUINUCLIDINYL BENZILATE; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; SJOGREN'S SYNDROME;

EID: 0030028494     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.42748.x     Document Type: Article

References (38)

1. Markusse H, Otten H, Vroom T, Smeets T, Fokkens N, Breedveld F. Rheumatoid factor isotypes in serum and salivary fluid of patients with primary Sjögren's syndrome. Clin Immunol Immunopathol 1993; 66:26-32.
2. Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjögren's syndrome: a clinical, pathological and serological study of sixty-two cases. Medicine 1965; 44:187-231.
3. Moutsopoulos HM, Chused TM, Mann DL. Sjögren's syndrome (sicca syndrome): current issues. Ann Int Med 1980; 92:212-26.
4. Talal N. Recent developments in the immunology of Sjögren's syndrome (autoimmune exocrinopathy). Scand J Rheumatol 1986; 61:76-82.
5. Atkinson JC, Fox PC, Travis WD. IgA rheumatoid factor and IgA containing immune complexes in primary Sjögren's syndrome. J Rheumatol 1989; 16:1205-10.
6. Bendaoud B, Pennec YL, Lelong A. IgA-containing immune complexes in the circulation of patients with primary Sjögren's syndrome. J Autoimmun 1991; 4:177-84.
7. Bacman S, Sterin-Borda L, Camusso JJ, Hubscher O, Arana R, Borda E. Circulating antibodies against neurotransmitter receptor activities in children with congenital heart block and their mothers. FASEB J 1994; 8: 1170-6.
8. Mandel ID, Baurmash H. Sialochemistry in Sjögren's syndrome. Oral Surg 1976; 41:182-7.
9. Stuchell RN, Mandel ID, Baurmash H. Clinical utilization of sialochemistry in Sjögren's syndrome. J Oral Pathol 1984; 13:303-9.
10. Pennec Y, Ferrec C, Youinou P. Lyzozyme, immunoglobulins et beta-2-microglobuline salivaire au cours du syndrome de Gougerot-Sjögren. Nouv Press Med 1982; 11:3481-4.
11. Elkon KB, Gharavi AE, Patel BM, Hughes GRV, Frankel A. IgA and IgM rheumatoid factors in serum, saliva and other secretions: relationship to immunoglobulin ratios in systemic sicca syndrome and rheumatoid arthritis. Clin Exp Immunol. 1983; 52:75-84.
12. Muller K, Oxholm P, Hoier-Madsen M, Wiik A. Circulating IgA and IgM rheumatoid factors in patients with primary Sjögren's syndrome. Scand J Rheumatol 1989; 18:29-31.
13. Dunne JV, Carson DA, Spiegelberg HL, Alspaugh MA, Vaughan JH. IgA rheumatoid factor in sera and saliva of patients with rheumatoid arthritis and Sjögren's syndrome. Ann Rheum Dis 1979; 38:161-5.
14. Horsfall AC, Rose LM, Maini RN. Autoantibody synthesis in salivary glands of Sjögren's syndrome patients. J Autoimmun 1989; 2:559-68.
15. Kausman D, Allen ME, Snaith ML, Isenberg DA. Autoimmunity and the clinical spectrum of Sjögren's syndrome. In: Isenberg DA, Horsfall AC, eds. Autoimmune diseases: focus on Sjögren's syndrome. Oxford: BIOS Scientific Publishers Ltd., 1994:1-20.
16. Hootman SR, Picado-Leonard TM, Burnham DB. Muscarinic acetylcholine receptor structure in acinar cells of mammalian exocrine glands. J Biol Chem 1994; 260:4186-94.
17. Oron Y, Creacy S, Kellogg J, Larner J. Stable cholinergic muscarinic and alpha adrenergic inhibition of rat parotid adenylate cyclase. J Cyc Nucl Res 1980; 6:105-20.
18. Hosey MM. Diversity of structure, signaling and regulation within the family of muscarinic cholinergic receptors. FASEB J 1992; 6:845-52.
19. 3 muscarinic receptors in rat parotid gland couple to two second messenger systems. Am J Physiol 1991; 221:C1063-73.
20. Kurata N, Tan EM. Identification of antibodies to nuclear acidic antigens by counter immunoelectrophoresis. Arthritis Rheum 1976; 19:574-80.
21. Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acad Sci 1949; 51:660-72.
22. Brown BL, Albano JD, Ekins RP, Sgherzi AH. Simple and selective assay method for the measurement of cyclic AMP Biochem J 1971; 121:561-2.
23. Berridge MJ, Downes CP, Hauley MR. Lithium amplifies agonist dependent phosphatydilinositol responses in brain and salivary glands. Biochem J 1982; 206:539-44.
24. Cremaschi GA, Sterin-Borda L. Stimulation of phosphoinositide hydrolysis via class I antigen-specific recognition in murine cardiac tissue. FEBS Lett 1989; 249:302-6.
25. 3H]-inositol on silica gel glass-fiber sheets. J Chromalogr 1976; 120:502-5.
26. Goren N, Perez Leiros C, Sterin-Borda L, Borda E. Phosphoinositide hydrolysis mediated by H1 receptors in autoimmune myocarditis. Med Immflam 1993; 2:317-22.
27. Walenga R, Vanderhoek JY, Feinstein MB. Serine esterase inhibitors block stimulus-induced mobilization of arachidonic acid and phosphatidylinositol specific phospholipase C activity in platelets. J Biol Chem 1986; 255:6024-7.
28. Mellgren SI, Conn DL, Stevens JC, Dyck PJ. Peripheral neuropathy in primary Sjögren's syndrome. Neurology 1989; 39:390-4.
29. Fleming JR, Wisler PL, Watanabe AM. Signal transduction by G proteins in cardiac tissues. Circulation 1992; 85:420-30.
30. Hepler JR, Hughes AR, Harden TK. Evidence that muscarinic cholinergic receptors selectively interact with either the cyclic AMP or the inositol phosphate second-messenger response system. Biochem J 1987; 247:793-6.
31. Woon PY, Jeyaseelan K, Thiyagarajah P. Adrenergic regulation of RNA synthesis in the rat parotid gland. Biochem Pharmacol 1993; 45:1395-401.
32. Harper JF, Brooker G. Refractoriness to muscarinic and adrenergic agonists in rat parotid: response of adenosine and guanosine cyclic 3′,5′-monophosphates. Mol Pharmacol 1977; 13:1048-59.
33. Provost TT, Talal M, Harley JB. The relationship between anti-Ro(SS-A) antibody positive Sjögren's syndrome and anti Ro(SS-A) antibody positive lupus erythematosus. Arch Dermatol 1988; 124:63-71.
34. Pease CT, Charles PJ, Shackles W, Markwick J, Maim RN. Serological and immunogenetic markers of extraglandular primary Sjögren's syndrome. Br J Rheumatol 1993; 32:574-577.
35. Goin JC,i Borda E, Perez Leiros C, Storino R, Sterin-Borda L. Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications. J Aut Nerv Syst 1994; 47:45-52.
36. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against beta adrenoceptors in human idiopathic dilated cardiomyopathy. Circulation Res 1989; 64:97-103.
37. Sterin-Borda, Borda E. Participation of autonomie nervous system in the pathogenesis of Chagas' disease (review). Acta Physiol Pharm Therap Latinoam 1994; 44:109-23.
38. Alexander JM, Hirsch TJ, Arnett FC, Provost TT, Stevens MB. Ro(SS-A) and La(SS-B) antibodies in the clinical spectrum of Sjögren's syndrome. J Rheumatol 1982; 9:239-46.